<VariationArchive RecordType="classified" VariationID="1071137" VariationName="NM_206965.2(FTCD):c.293dup (p.Val99fs)" VariationType="Duplication" Accession="VCV001071137" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2021-05-10" MostRecentSubmission="2021-05-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1064935" VariationID="1071137">
      <GeneList>
        <Gene Symbol="FTCD" FullName="formimidoyltransferase cyclodeaminase" GeneID="10841" HGNC_ID="HGNC:3974" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>21q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="46136262" stop="46155579" display_start="46136262" display_stop="46155579" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NT_187626.1" start="4876" stop="14638" display_start="4876" display_stop="14638" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="47556175" stop="47575480" display_start="47556175" display_stop="47575480" Strand="-" />
          </Location>
          <OMIM>606806</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_206965.2(FTCD):c.293dup (p.Val99fs)</Name>
      <CanonicalSPDI>NC_000021.9:46152980:CCCC:CCCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>21q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="46152980" stop="46152981" display_start="46152980" display_stop="46152981" variantLength="1" positionVCF="46152980" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="47572894" stop="47572895" display_start="47572894" display_stop="47572895" variantLength="1" positionVCF="47572894" referenceAlleleVCF="G" alternateAlleleVCF="GC" />
      </Location>
      <ProteinChange>V99fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.8" sequenceAccession="NC_000021" sequenceVersion="8" change="g.47572898dup" Assembly="GRCh37">
            <Expression>NC_000021.8:g.47572898dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.9" sequenceAccession="NC_000021" sequenceVersion="9" change="g.46152984dup" Assembly="GRCh38">
            <Expression>NC_000021.9:g.46152984dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016191.1" sequenceAccession="NG_016191" sequenceVersion="1" change="g.7587dup">
            <Expression>NG_016191.1:g.7587dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001320412.2" sequenceAccession="NM_001320412" sequenceVersion="2" change="c.293dup">
            <Expression>NM_001320412.2:c.293dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001307341.1" sequenceAccession="NP_001307341" sequenceVersion="1" change="p.Val99fs">
            <Expression>NP_001307341.1:p.Val99fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006657.3" sequenceAccession="NM_006657" sequenceVersion="3" change="c.293dup">
            <Expression>NM_006657.3:c.293dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006648.1" sequenceAccession="NP_006648" sequenceVersion="1" change="p.Val99fs">
            <Expression>NP_006648.1:p.Val99fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_206965.2" sequenceAccession="NM_206965" sequenceVersion="2" change="c.293dup" MANESelect="true">
            <Expression>NM_206965.2:c.293dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_996848.1" sequenceAccession="NP_996848" sequenceVersion="1" change="p.Val99fs">
            <Expression>NP_996848.1:p.Val99fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1310075515" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_206965.2(FTCD):c.293dup (p.Val99fs) AND Glutamate formiminotransferase deficiency" Accession="RCV001383517" Version="1">
        <ClassifiedConditionList TraitSetID="1099">
          <ClassifiedCondition DB="MedGen" ID="C0268609">Glutamate formiminotransferase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-07-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-07-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2021-05-10">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">29178637</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29869163</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1099" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1296" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Formiminotransferase deficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Formiminoglutamicaciduria (FIGLU-uria)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Formiminoglutamic acidemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Arakawa syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glutamate formiminotransferase deficiency</ElementValue>
                <XRef ID="59761008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Formiminoglutamic aciduria</ElementValue>
                <XRef ID="MONDO:0009240" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Glutamate formiminotransferase deficiency is an autosomal recessive disorder and the second most common inborn error of folate metabolism. Features of a severe phenotype include elevated levels of formiminoglutamate (FIGLU) in the urine in response to histidine administration, megaloblastic anemia, and mental retardation. Features of a mild phenotype include high urinary excretion of FIGLU in the absence of histidine administration, mild developmental delay, and no hematologic abnormalities (summary by Hilton et al., 2003).</Attribute>
                <XRef Type="MIM" ID="229100" DB="OMIM" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9279" />
                <XRef ID="9279" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="51208" DB="Orphanet" />
              <XRef ID="C0268609" DB="MedGen" />
              <XRef ID="MONDO:0009240" DB="MONDO" />
              <XRef Type="MIM" ID="229100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3108294" SubmissionDate="2021-01-07" DateLastUpdated="2021-05-10" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="11126812|MedGen:C0268609" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001582668" DateUpdated="2021-05-10" DateCreated="2021-05-10" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-07-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29178637</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29869163</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val99Argfs*5) in the FTCD gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with FTCD-related conditions. Loss-of-function variants in FTCD are known to be pathogenic (PMID: 29178637, 29869163). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FTCD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.8:g.47572894_47572895insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268609" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3108294" TraitType="Disease" MappingType="XRef" MappingValue="C0268609" MappingRef="MedGen">
        <MedGen CUI="C0268609" Name="Glutamate formiminotransferase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

